We compared the inoculum effects for 109 recent clinical isolates of the Bacteroidesfragilis group of cefoxitin, cefotetan, ceftizoxime, ceftriaxone, and three (3-lactamase inhibitors (clavulanic acid, sulbactam, and tazobactam) and their penicillin-derived components. Bactericidal activity was assayed and morphologic changes were monitored for selected strains exhibiting a large inoculum effect. Ceftizoxime demonstrated the largest inoculum effect, followed by cefotetan and ceftriaxone. The large inoculum effect of ceftizoxime and ceftriaxone was correlated with filamentous transformation at the high inoculum (108 CFU/ml) and lack of bactericidal activity suggesting drug destruction or inactivation. Cefotetan was bactericidal for B. fragilis isolates but not for other members of the B. fragilis group. Cefoxitin showed the least inoculum effect and was consistently bactericidal at high (108 CFU/ml), standard (106 CFU/ml), and low (104 CFU/ml) inocula, followed by ampicillin-sulbactam. Piperacillin-tazobactam and ticarcillin-clavulanic acid showed an intermediate inoculum effect. The degree of inoculum effect observed generally correlated with bactericidal activity at all inocula.The inoculum effect, a large increase in the MIC occurring with an increase in the inoculum size of a microorganism, is one of the variables that influence susceptibility testing and occurs primarily with beta-lactam antibiotics (7,8,11,16). A number of studies have shown that the Bacteroides fragilis group species produce 1-lactamases and may exhibit an inoculum effect (3,5,7,16,23,24). Sutter et al. (21) have suggested that both large and small inocula should be used to detect resistance of anaerobic bacteria to beta-lactam agents. In a recent review on the inoculum effect, Brook (7) summarized the laboratory experience to date with B. fragilis group species and noted that while some of the cephalosporins had been studied, there was scant data on the P-lactamase inhibitor combinations and their penicillin-derived components (1,3,17,18